Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep421 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The effects of Semaglutide on glycaemic control and weight, in type two diabetic patients, in our diabetic day center

Al-Shaibany Azhar , Mc Cabe Olivia , Shabaht Shah

Introduction: Type two diabetes is characterized by a chronic metabolic state (obesity, high blood pressure, and dyslipidemia) and insulin resistance. There is insufficient pancreatic insulin production and ineffective use of the produced insulin resulting in abnormally high blood glucose levels (hyperglycaemia). Metabolic syndrome and diabetes are associated with increased cardiovascular risk, reduced life expectancy and a reduction in quality of life. Glucagon-like peptide 1...